Related Experiment Video
Updated: Feb 16, 2026

A Novel Ex vivo Culture Method for the Embryonic Mouse Heart
Published on: May 24, 2013
Intact calcium signaling in adrenergic-deficient embryonic mouse hearts
Jessica N Peoples1, David G Taylor1, Alexander N Katchman2
1Burnett School of Biomedical Sciences, Division of Metabolic and Cardiovascular Sciences, College of Medicine, University of Central Florida, 6900 Lake Nona Blvd, Orlando, FL 32827, United States.
Insights
Embryonic mouse hearts lacking adrenergic hormones survive due to intact calcium signaling. This research shows that adrenergic deficiency doesn't impair cardiac calcium signaling, suggesting it's not the cause of heart failure in these embryos.
Area of Science:
- Cardiovascular Physiology
- Developmental Biology
- Molecular Cardiology
Background:
- Adrenergic hormones, norepinephrine (NE) and epinephrine (EPI), are vital for cardiac function.
- Deficiencies in cardiac calcium signaling are linked to heart failure.
- Dbh-/- mouse embryos lack NE and EPI, leading to embryonic lethality from heart failure around E10.5.
Purpose of the Study:
- To investigate if adrenergic deficiency in embryonic mouse hearts causes impaired cardiac calcium signaling before the onset of heart failure.
- To determine the role of adrenergic hormones in the development of embryonic cardiac calcium signaling.
Main Methods:
- Ratiometric fluorescent calcium imaging to measure cytosolic calcium transients ([Ca2+]i) in isolated E10.5 mouse hearts.
- Stimulation with extracellular calcium, caffeine, and NE.
- Immunofluorescent histochemical staining for calcium channel distribution.
- Patch-clamp recording to assess L-type calcium current (ICa,L) activity.
Main Results:
- Spontaneous [Ca2+]i oscillations were present and responded normally to stimuli in adrenergic-deficient hearts.
- Distribution and activity of the L-type calcium channel (ICa,L) were similar in both deficient and control embryonic hearts.
- Intracellular and extracellular calcium signaling pathways were functional in E10.5 adrenergic-deficient hearts.
Conclusions:
- Adrenergic hormones are not essential for the development of functional intracellular calcium oscillations or extracellular calcium signaling via ICa,L in embryonic hearts.
- Aberrant calcium signaling is unlikely to be the primary cause of heart failure in Dbh-/- mouse embryos.
- Cardiac development and function can proceed without adrenergic signaling up to E10.5.
Abstract:
Mouse embryos that lack the ability to produce the adrenergic hormones, norepinephrine (NE) and epinephrine (EPI), due to disruption of the dopamine beta-hydroxylase (Dbh-/-) gene inevitably perish from heart failure during mid-gestation. Since adrenergic stimulation is well-known to enhance calcium signaling in developing as well as adult myocardium, and impairments in calcium signaling are typically associated with heart failure, we hypothesized that adrenergic-deficient embryonic hearts would display deficiencies in cardiac calcium signaling relative to adrenergic-competent controls at a developmental stage immediately preceding the onset of heart failure, which first appears beginning or shortly after mouse embryonic day 10.5 (E10.5). To test this hypothesis, we used ratiometric fluorescent calcium imaging techniques to measure cytosolic calcium transients, [Ca2+]i in isolated E10.5 mouse hearts. Our results show that spontaneous [Ca2+]i oscillations were intact and robustly responded to a variety of stimuli including extracellular calcium (5 mM), caffeine (5 mM), and NE (100 nM) in a manner that was indistinguishable from controls. Further, we show similar patterns of distribution (via immunofluorescent histochemical staining) and activity (via patch-clamp recording techniques) for the major voltage-gated plasma membrane calcium channel responsible for the L-type calcium current, ICa,L, in adrenergic-deficient and control embryonic cardiac cells. These results demonstrate that despite the absence of vital adrenergic hormones that consistently leads to embryonic lethality in vivo, intracellular and extracellular calcium signaling remain essentially intact and functional in embryonic mouse hearts through E10.5. These findings suggest that adrenergic stimulation is not required for the development of intracellular calcium oscillations or extracellular calcium signaling through ICa,L and that aberrant calcium signaling does not likely contribute to the onset of heart failure in this model.
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Anatomy of the Heart
Cell-surface Signaling
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...

